- 米国企業
- Moderna, Inc.
Moderna, Inc.MRNA
時価総額
PER
2018年 12月31日 | 2019年 12月31日 | 2020年 12月31日 | 2021年 12月31日 | 2022年 12月31日 | 2023年 12月31日 | |
Net product sales | - | - | 200 | 17,675 | 18,435 | 6,671 |
Grant revenue | 13 | 12 | 529 | 735 | 388 | 94 |
Other revenue | - | - | - | - | - | 177 |
Collaboration revenue | 77 | 43 | 75 | 61 | 440 | - |
Total revenue | 135 | 60 | 803 | 18,471 | 19,263 | 6,848 |
Cost of sales | - | - | 8 | 2,617 | 5,416 | 4,693 |
Research and development | 454 | 496 | 1,370 | 1,991 | 3,295 | 4,845 |
General and Administrative Expense | 94 | 110 | 188 | 567 | 1,132 | 1,549 |
Total operating expenses | - | - | 1,567 | 5,175 | 9,843 | 11,087 |
(Loss) income from operations | -413 | -546 | -763 | 13,296 | 9,420 | -4,239 |
Interest income | 27 | 39 | 25 | 18 | 200 | 421 |
Other expense, net | 2 | -8 | -6 | -29 | -45 | -124 |
(Loss) income before income taxes | -384 | -515 | -745 | 13,285 | 9,575 | -3,942 |
Provision for income taxes | 0 | -1 | 3 | 1,083 | 1,213 | 772 |
Net (loss) income | -385 | -514 | -747 | 12,202 | 8,362 | -4,714 |
Basic (in usd per share) | - | - | - | 30.31 | 21.26 | -12.33 |
Diluted (in usd per share) | - | - | - | 28.29 | 20.12 | -12.33 |